GBIM:OTCMKTS
GlobeImmune Inc
0,00010 USD
0,00%
(0,00) 1G
29 set, 15:48:52 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per GBIM in corso…
Cap. mercato
580,00
Vol. medio
1,74K
Volume
0,00
Max 52 sett.
0,04 USD
Min 52 sett.
0,00 USD
Azioni in circolazione
5,75 Mln
N. di dipendenti
22
Cap. mercato
580,00
Vol. medio
1,74K
Volume
0,00
Max 52 sett.
0,04 USD
Min 52 sett.
0,00 USD
Azioni in circolazione
5,75 Mln
N. di dipendenti
22
Articoli giornalistici
Da fonti web e partner giornalistici
Borsa Italiana
·
1 ora fa
Borsa: Lieve rialzo per il Dow Jones, in crescita dello 0,41% alle 19:30
Benzinga Italia
·
3 ore fa
SpaceX guadagna il 22% in due mesi e batte l'S&P 500: l'analisi
Profilo
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.
The company has partnerships with Celgene and the National Cancer Institute for the development of cancer vaccines. Their collaboration with Gilead for the development of therapeutic vaccines for the treatment of hepatitis B was terminated in November 2016 after the product they were developing failed a clinical trial the year before.
With respect to financing in the absence of revenue, the company raised US$17,500,000 through a Series E Preferred Stock offering in January 2010.
As of August 2015, GlobeImmune had two therapeutic vaccines in clinical trials, GI-6207 and GI-6301, for the treatment of various cancers. Wikipedia
Informazioni su GlobeImmune Inc
CEO-
Dipendenti22
Data di fondazione1 gen 1995
SedeLouisville, Colorado, Stati Uniti
Settore-
Sito webglobeimmune.com